3 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 3 |
Follow Pneumococcal Infections: new trials by email Literature Review of Pneumococcal Infections trials Research Report on Pneumococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants Formulation B, Formulation C, Formulation D - Pneumococcal Disease, Invasive | Phase 2 | Active not recruiting | Inventprise Inc. | 421 | 2025-01-27 | 2025-09-02 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants 0.5 mL of the low dose VAX-31, 0.5 mL of the mid dose VAX-31, 0.5 mL of the high dose VAX-31 - Pneumococcal Vaccines | Phase 2 | Active not recruiting | Vaxcyte, Inc. | 900 | 2024-11-25 | 2026-05-15 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Infants PG4, 20-valent pneumococcal conjugate vaccine (20vPnC), 15-valent pneumococcal conjugate vaccine (PCV15) - Pneumococcal Disease | Phase 2 | Active not recruiting | Pfizer | 605 | 2024-07-25 | 2026-10-19 |
Pneumonia (1)
Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Gram-Positive Bacterial Infections (3) · Infections (3) · Streptococcal Infections (3) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
D-Worm (1)
Inventprise Inc. (1) · Pfizer (1) · Vaxcyte, Inc. (1)
Puerto Rico (2) · United States (2) · Philippines (1)
2025 (1)